A systematic molecular pathology study of a laboratory confirmed H5N1 human case

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Gao, Rongbao ^a   Dong, Libo ^a   Dong, Jie ^a   Wen, Leying ^a   Zhang, Ye ^a   Yu, Hongjie ^b   Feng, Zijian ^b   Chen, Minmei ^c   Tan, Yi ^c   Mo, Zhaojun ^c   Liu, Haiyan ^d   Fan, Yunyan ^d   Li, Kunxiong ^e   Li, Chris Ka Fai ^f   Li, Dexin ^a   Yang, Weizhong ^b   Shu, Yuelong ^a  

^a State Key Laboratory for Molecular Virology and Genetic Engineering   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention   (China)

^d Nanning Center for Disease Control and Prevention   (China)

^e FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MATRIX PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS HEMAGGLUTININ;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; COUGHING; DIGESTIVE SYSTEM; DYSPNEA; FEVER; GENE LOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LYMPHOID TISSUE; MALE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; THORAX RADIOGRAPHY; URINARY TRACT; VIRUS DETECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; FATALITY; GENETICS; INFLUENZA; ISOLATION AND PURIFICATION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

AVIAN INFLUENZA VIRUS;

ADULT; FATAL OUTCOME; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 78149422301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013315     Document Type: Article

References (53)

1. Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407-21.
2. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56(1): 152-79.
3. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, et al. (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279(5349): 393-6.
4. World Health Organization (2009) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to who. Available at: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_ 12_30/en/index.html.
5. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, et al. (2005) Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352(4): 333-40.
6. Chen H, Smith GJ, Zhang SY, Qin K, Wang J, et al. (2005) Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 436(7048): 191-2.
7. Lee MS, Chang PC, Shien JH, Cheng MC, Shieh HK (2001) Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J Virol Methods 97(1-2): 13-22.
8. Van Borm S, Thomas I, Hanquet G, Lambrecht B, Boschmans M, et al. (2005) Highly pathogenic H5N1 influenza virus in smuggled Thai eagles, Belgium. Emerg Infect Dis 11(5): 702-5.
9. Komar N, Olsen B (2008) Avian influenza virus (H5N1) mortality surveillance. Emerg Infect Dis 14(7): 1176-8.
10. World Health Organization (2009) Influenza A (H1N1): pandemic alert phase 6 declared, of moderate severity. Available at: http://www.euro.who.int/influenza/AH1N1/20090611_11.
11. Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH (2006) Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 368(9554): 2211-8.
12. Peiris JS, de Jong MD, Guan Y (2007) Avian Influenza Virus (H5N1): a Threat to Human Health. Clin Microbiol Rev 20(2): 243-67.
13. Yu H, Shu Y, Hu S, Zhang H, Gao Z, et al. (2006) The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet 367(9504): 84.
14. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, et al. (2004) Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350(12): 1179-88.
15. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, et al. (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353(13): 1374-85.
16. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, et al. (2005) Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 11(2): 201-9.
17. Yu H, Gao Z, Feng Z, Shu Y, Xiang N, et al. (2008) Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 3(8): e2985.
18. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, et al. (1998) Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351(9101): 467-71.
19. Buchy P, Mardy S, Vong S, Toyoda T, Aubin JT, et al. (2007) Influenza A/ H5N1 virus infection in humans in Cambodia. J Clin Virol 39: 164-168.
20. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, et al. (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352(7): 686-91.
21. To KF, Chan PK, Chan KF, Lee WK, Lam WY, et al. (2001) Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63(3): 242-6.
22. Chu VC, Whittaker GR (2004) Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci U S A 101(52): 18153-8.
23. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med 12(10): 1203-7.
24. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, et al. (2004) Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363(9409): 617-9.
25. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360(9348): 1831-7.
26. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, et al. (2005) Influenza A H5N1 replication sites in humans. Emerg Infect Dis 11(7): 1036-41.
27. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, et al. (2007) H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370(9593): 1137-45.
28. Fujimoto S, Kobayashi M, Uemura O, Iwasa M, Ando T, et al. (1998) PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet 352(9131): 873-5.
29. Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, et al. (2004) Atypical avian influenza (H5N1). Emerg Infect Dis 10(7): 1321-4.
30. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, et al. (2007) Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 13(5): 708-12.
31. Chutinimitkul S, Bhattarakosol P, Srisuratanon S, Eiamudomkan A, Kongsomboon K, et al. (2006) H5N1 influenza A virus and infected human plasma. Emerg Infect Dis 12(6): 1041-3.
32. Gu J, Gong E, Zhang B, Zheng J, Gao Z, et al. (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med. 202(3): 415-24.
33. Mok CK, Lee DC, Cheung CY, Peiris M, Lau AS (2007) Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 88(Pt 4,. pp 1275-80.
34. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2006) H5N1 virus attachment to lower respiratory tract. Science 312(5772): 399.
35. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13(2): 147-9.
36. La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of selfpreservation: immunopathology in influenza virus infection. Immunol Cell Biol 85(2): 85-92.
37. Li YG, Thawatsupha P, Chittaganpitch M, Rungrojcharoenkit K, Li GM, et al. (2008) Higher in vitro susceptibility of human T cells to H5N1 than H1N1 influenza viruses. Biochem Biophys Res Commun 371(3): 484-9.
38. Takahashi T, Suzuki Y, Nishinaka D, Kawase N, Kobayashi Y, et al. (2001) Duck and human pandemic influenza A viruses retain sialidase activity under low pH conditions. J Biochem 130(2): 279-83.
39. Suzuki Y, Ito T, Suzuki T, Holland RE, Jr., Chambers TM, et al. (2000) Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 74(24): 11825-31.
40. Korteweg C, Gu J (2008) Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172(5): 1155-70.
41. Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, et al. (2005) Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol 86(Pt 4): 1121-30.
42. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106(9): 3455-60.
43. Seo SH, Hoffmann E, Webster RG (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8(9): 950-4.
44. Fehrenbach H (2001) Alveolar epithelial type II cell: Defender of the alveolus revisited. Respir Res 2(1): 33-46.
45. Sharma AK, Fernandez LG, Awad AS, Kron IL, Laubach VE (2007) Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 293(1): L105-113.
46. Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, et al. (2002) Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J Infect Dis 185(8): 1139-47.
47. Krücken J, Mehnert LI, Dkhil MA, El-Khadragy M, Benten WP, et al. (2005) Massive destruction of malaria-parasitized red blood cells despite spleen closure. Infect Immun 73(10): 6390-8.
48. Li L, Gu J, Shi X, Gong E, Li X, et al. (2005) Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and Prospects. Clin Infect Dis 41(6): 815-21. 1.
49. Fronhoffs S, Totzke G, Stier S, Wernert N, Rothe M, et al. (2002) A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes 16(2): 99-110.
50. World health organization (2005) Recommended laboratory tests to identify avian influenza A virus in specimens from humans. Available at: http://www.who.int/csr/disease/avian_influenza/guidelines/avian_labtests 2.pdf.
51. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, et al. (2006) Functional Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Production by Avian Influenza Virus-Infected Macrophages. J Infect Dis 193(7): 945-53.
52. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, et al. (2006) Differential Expression of Chemokines and Their Receptors in Adult and Neonatal Macrophages Infected with Human or Avian Influenza Viruses. J Infect Dis 194(1): 61-70.
53. Di Trani L, Bedini B, Donatelli I, Campitelli L, Chiappini B, et al. (2006) A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control. BMC Infect Dis 6: 87.